Table 2 Evaluation of multiple diagnostic parameters at various stages
From: A 28-year-old male patient with asymptomatic and multi-drug-resistant HBV infection: a case report
Parameters | Normal ranges | Initial stage (2016) | After 1 year (2017) | After 2 years (2018) | After 3 years (2019) | After 4 years (2020) | After 5 years (2021) | After 6 years (2022) |
|---|---|---|---|---|---|---|---|---|
Blood diagnostic results at various stages | ||||||||
ALT | 29 to 33 IU/L | 41 | 53 | 48 | 55 | 57 | 49 | 52 |
ALP | 44 to 147 IU/L | 29 | 33 | 48 | 57 | 71 | 102 | 123 |
Total bilirubin | 0.1 to 1.2 mg/dL | 0.59 | 0.58 | 0.51 | 0.60 | 0.55 | 0.50 | 0.55 |
TG | Up to 199 mg/dL | 78 | 69 | 75 | 68 | 74 | 81 | 79 |
Cholesterol | Up to 200 mg/dL | 142 | 147 | 125 | 129 | 147 | 139 | 144 |
HDL | 35 to 55 mg/dL | 45 | 39 | 47 | 42 | 48 | 40 | 43 |
LDL | 10 to 140 mg/dL | 94 | 99 | 82 | 87 | 76 | 101 | 90 |
TLC | 5000 to 10000 cells/µL | 5900 | 6300 | 8500 | 7200 | 8100 | 6900 | 7400 |
Platelets | 135,000 to 317,000 per µL | 167,000 | 163,000 | 159,000 | 271,000 | 264,000 | 195,000 | 210,000 |
RBCs | 4.7 to 6.1 million cells/µL | 5.25 | 5.25 | 5.40 | 5.61 | 5.10 | 5.30 | 5.0 |
Hct | 38 to 50% | 51 | 49% | 50% | 42% | 43% | 49% | 44% |
Hb | 14 to 18 g/dl | 16.4 | 16.7 | 16.0 | 16.1 | 15.8 | 17.2 | 16.3 |
Urine examination results at various stages | ||||||||
Color | Clear to pale yellow | Pale yellow | Pale yellow | Pale yellow | Pale yellow | Pale yellow | Pale yellow | Pale yellow |
Specific gravity | 1.005 to 1.030 | 1.010 | 1.007 | 1.025 | 1.015 | 1.020 | 1.015 | 1.015 |
PH | 4.5 to 8.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 |
Sugar | 0 to 0.8 mmol/L | Nil | Nil | Nil | Nil | Nil | Nil | Nil |
Urobilinogen | Up to 1.0 mg/dL | Normal | Normal | Normal | Normal | Normal | Normal | Normal |
Puss cells | 0–5/ HPF | 0–1 | 2–3 | 1–2 | 0–1 | 1–2 | 1–2 | 4–5 |
RBCs | ≤ 2 cells/ HPF | Nil | Nil | Nil | Nil | Nil | Nil | Nil |
Epithelial cells | ≤ 2–5 cells/HPF | 1–2 | 0–1 | 1–2 | 0–1 | 2–3 | 0–1 | 1–2 |